Cronos Group Inc. (CVE:MJN) – Analysts at Beacon Securities lowered their Q3 2018 EPS estimates for Cronos Group in a note issued to investors on Friday. Beacon Securities analyst V. Ajamain now anticipates that the company will earn $0.00 per share for the quarter, down from their prior estimate of $0.01. Beacon Securities also issued estimates for Cronos Group’s Q4 2018 earnings at $0.00 EPS, Q1 2019 earnings at $0.01 EPS, Q2 2019 earnings at $0.01 EPS and Q3 2019 earnings at $0.02 EPS.

Shares of Cronos Group (MJN) opened at C$4.18 on Monday. Cronos Group has a 12-month low of C$1.35 and a 12-month high of C$4.78.

COPYRIGHT VIOLATION WARNING: This news story was originally reported by American Banking News and is owned by of American Banking News. If you are accessing this news story on another website, it was copied illegally and republished in violation of US and international trademark and copyright legislation. The original version of this news story can be accessed at https://www.americanbankingnews.com/2017/12/04/q3-2018-earnings-estimate-for-cronos-group-inc-mjn-issued-by-beacon-securities.html.

About Cronos Group

Cronos Group, formerly known as PharmaCan Capital Corp., is a principal investment firm. The firm seeks to invest in companies either licensed, or actively seeking a license, to produce medical marijuana pursuant to Canada’s Marihuana for Medical Purposes Regulations (“MMPR”). The firm typically invests in companies based in Canada.

Receive News & Ratings for Cronos Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cronos Group Inc. and related companies with MarketBeat.com's FREE daily email newsletter.